Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Hester Biosciences financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.


₹3 B

FY, 2024

CreditSafe Score

Score changed on Jul 17, 2024
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn more

Financial Statements

INRFY, 2018FY, 2019FY, 2020FY, 2021FY, 2022FY, 2023FY, 2024
Cost of goods sold242.7M345.5M238.5M528.1M661.1M810.0M958.8M
Gross profit1.1B1.5B1.6B1.6B1.8B2.0B2.2B
Gross profit margin, %85.3%84.9%95.5%83.8%78.1%75.5%72.0%
Operating expense total640.3M753.3M1.0B924.6M1.1B1.3B1.6B
Depreciation and amortization96.6M117.6M132.3M133.1M165.8M207.0M171.7M
EBITDA margin, %37.6%42.4%35.2%36.8%31.4%25.7%22.6%
EBIT margin, %30.1%35.8%27.5%28.4%24.0%17.8%17.0%
Interest income810.0K1.5M3.7M12.9M19.0M21.7M
Interest expense40.4M66.3M76.7M66.0M35.3M54.8M197.8M
Pre tax profit361.2M568.6M413.3M501.0M535.0M401.5M319.5M
Income tax expense130.5M161.6M103.2M154.1M140.2M121.2M107.9M
Net Income230.7M406.9M310.0M347.0M394.8M280.4M211.7M

Footer menu